PEGYLATED INTERFERON-LAMBDA (PEGIFN-λ) SHOWS SUPERIOR VIRAL RESPONSE WITH IMPROVED SAFETY AND TOLERABILITY VERSUS PEGIFNα-2A IN HCV PATIENTS (G1/2/3/4): EMERGE PHASE IIB THROUGH WEEK 12

被引：32

作者：

Zeuzem, S. ^{[1
]}

Arora, S. ^{[2
]}

Bacon, B. ^{[3
]}

Box, T. ^{[4
]}

Charlton, M. ^{[5
]}

Diago, M. ^{[6
]}

Dieterich, D.

Esteban Mur, R. ^{[7
]}

Everson, G. ^{[8
]}

Fallon, M. ^{[9
]}

Ferenci, P. ^{[10
]}

Flisiak, R. ^{[11
]}

George, J. ^{[12
,13
]}

Ghalib, R. ^{[14
]}

Gitlin, N. ^{[15
]}

Gladysz, A. ^{[16
]}

Gordon, S. ^{[17
]}

Greenbloom, S. ^{[18
]}

Hassanein, T. ^{[19
]}

Jacobson, I. ^{[20
]}

Jeffers, L. ^{[21
]}

Kowdley, K. ^{[22
]}

Lawitz, E. ^{[23
]}

Lee, S. ^{[24
]}

Leggett, B. ^{[25
]}

Lueth, S. ^{[26
]}

Nelson, D. ^{[27
]}

Pockros, P. ^{[28
]}

Rodriguez-Torres, M. ^{[29
]}

Rustgi, V. ^{[30
]}

Serfaty, L. ^{[31
]}

Sherman, M. ^{[32
]}

Shiffman, M. ^{[33
]}

Sola, R. ^{[34
]}

Sulkowski, M. ^{[35
]}

Vargas, H. ^{[36
]}

Vierling, J. ^{[37
]}

Yoffe, B. ^{[38
]}

Ishak, L. ^{[39
]}

Fontana, D. ^{[39
]}

Xu, D. ^{[40
]}

Lester, J. ^{[39
]}

Gray, T. ^{[39
]}

Horga, A. ^{[40
]}

Hillson, J. ^{[39
]}

Ramos, E. ^{[39
]}

Lopez-Talavera, J. C. ^{[40
]}

Muir, A. ^{[41
]}

机构：

[1] Klinikum Johann Wolfgang Goethe Univ, Frankfurt, Germany

[2] Univ New Mexico, Albuquerque, NM 87131 USA

[3] St Louis Univ Med Ctr, St Louis, MN USA

[4] Univ Utah, Salt Lake City, UT USA

[5] Mayo Clin Rochester, Rochester, MN USA

[6] Clin Quiron Valencia Patol Digest, Valencia, Spain

[7] Hosp Univ Vall dHebron, Barcelona, Spain

[8] Univ Colorado Denver & Hosp, Aurora, CO USA

[9] Univ Texas Hlth Sci Ctr Houston, Houston, TX USA

[10] AKH Wien Univ Kliniken, Vienna, Austria

[11] Uniwersytetu Medycznego Bialymstoku, Bialystok, Poland

[12] Westmead Hosp, Westmead, NSW 2145, Australia

[13] Univ Sydney, Westmead, NSW 2145, Australia

[14] N Texas Res Inst, Arlington, TX USA

[15] Atlanta Gastroenterol Associates, Atlanta, GA USA

[16] Przychodnia Przy Ul Lowieckiej, Wroclaw, Poland

[17] Henry Ford Hosp, Detroit, MI 48202 USA

[18] Toronto Digest Dis Associates Inc, Vaughan, ON, Canada

[19] SCTI Res Fdn, Coronado, CA USA

[20] Weill Cornell Med Coll, New York, NY USA

[21] Miami VA Med Ctr, Miami, FL USA

[22] Virginia Mason Med Ctr, Seattle, WA 98101 USA

[23] Alamo Med Res, San Antonio, TX USA

[24] Univ Calgary, Calgary, AB, Canada

[25] Royal Brisbane & Womans Hosp, Herston, Qld, Australia

[26] Univ Klinikum Hamburg Eppendorf, Hamburg, Germany

[27] Univ Florida, Coll Med, Gainesville, FL USA

[28] Scripps Hlth DBA Scripps Clin Res Serv, La Jolla, CA USA

[29] Fdn Invest Diego, San Juan, PR USA

[30] Metropolitan Res, Fairfax, VA USA

[31] Hosp St Antoine, Paris, France

[32] Toronto Gen Hosp, Toronto, ON, Canada

[33] Bon Secours Mary Immaculate Hosp, Newport News, VA USA

[34] Hosp Mar Barcelona, Barcelona, Spain

[35] JHU Rockland Phys Practice & Res Grp, Lutherville Timonium, MD USA

[36] Mayo Clin Arizona, Phoenix, AZ USA

[37] Baylor Coll Med, Adv Liver Therapies St Lukes Episcopal Hosp, Houston, TX 77030 USA

[38] VAMC Baylor Coll Med, Houston, TX USA

[39] ZymoGenet BMS, Seattle, WA USA

[40] Bristol Myers Squibb Co, Wallingford, CT 06492 USA

[41] Duke Univ, Med Ctr, Durham, NC USA

来源：

JOURNAL OF HEPATOLOGY | 2011年 / 54卷

关键词：

D O I：

10.1016/S0168-8278(11)61362-7

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

1360

引用

页码：S538 / S539

页数：2